Also published in Digital Journal:
Proxy season results show dramatic shift in company-shareholder engagement
x hide permanently

Dthera Sciences Appoints Steve R. Martin to Board of Directors

Digital Journal

SAN DIEGO, CA / ACCESSWIRE / April 16, 2018 / Dthera™ Sciences (OTCQB: DTHR), a digital therapeutics company focused on developing the innovative quality of life therapies for the elderly and those suffering from cognitive decline, today announced the appointment of a Steve R. Martin, to the ...

Mentions: CEO CFO Wall Street